PTH and secondary hyperparathyroidism: PTX has emerged as a standard therapeutic intervention aimed at addressing secondary hyperparathyroidism and its associated complications, such as UTC, by reducing parathyroid hormone (PTH) levels and controlling calcium-phosphorus imbalance [3, 4].